For the second year in a row Forbes magazine published its list of the most awe-inspiring group of rising stars in science and healthcare under the age of 30.
These rising stars are changing the way science, innovation and healthcare are progressing. BIO’s President and CEO Jim Greenwood had a conversation with Forbes 30 Under 30: The Rising Stars Transforming Science and Healthcare, Laura Deming, Isaac Kinde, Adina Mangubat, and Joshua Sommer. View their bios. Watch the keynote video.
James C. Greenwood
President and CEO
Biotechnology Industry Organization
Moderated by BIO’s President & CEO Jim Greenwood, the panel drew from Senator Simpson and Mr. Bowles inside the beltway knowledge and experience to discuss their non-partisan movement to put America on a better fiscal and economic path.
“Decisions about federal spending, deficits and tax policies have a huge impact on the environment in which our BIO member companies do the hard work of biotech innovation. Few are as knowledgeable about budget issues as Erskine Bowles and Alan Simpson. We look forward to hearing their ideas for how to ensure a strong economic future for America without compromising biotechnology's ability to move faster to heal, fuel and feed the world,” said BIO President & CEO Jim Greenwood.
Read the BIOtechNOW blog post about the keynote address.
Sen. Simpson first joined the United States Senate in 1978 and was soon elected by his peers to the position of the Assistant Majority Leader in 1984 and served Majority Leader Bob Dole in that capacity until 1994. He completed his final Senate term on January 3, 1997. >> See his bio.
Bowles, best known for his roles as SBA Administrator, Deputy Chief of Staff and Chief of Staff under President Clinton, worked at the direction of the President and with the Republican House of Representatives and Senate to negotiate the first balanced budget in a generation. >> See his bio.
Keynotes are open to Full Convention, Convention Access registrants, and registered media.